dc.creator | Stolpe, Michael | |
dc.date | 2001 | |
dc.date.accessioned | 2013-10-16T06:55:35Z | |
dc.date.available | 2013-10-16T06:55:35Z | |
dc.date.issued | 2013-10-16 | |
dc.identifier | Die Weltwirtschaft 0043-2652 2001 3 305-314 | |
dc.identifier | http://hdl.handle.net/10419/2657 | |
dc.identifier | ppn:336067364 | |
dc.identifier | RePEc:zbw:ifwkie:2657 | |
dc.identifier.uri | http://koha.mediu.edu.my:8181/xmlui/handle/10419/2657 | |
dc.language | deu | |
dc.rights | http://www.econstor.eu/dspace/Nutzungsbedingungen | |
dc.subject | ddc:330 | |
dc.subject | AIDS | |
dc.subject | Pharmazeutisches Produkt | |
dc.subject | Patent | |
dc.subject | Gesundheitsfinanzierung | |
dc.subject | Gesundheitsökonomik | |
dc.subject | Entwicklungsländer | |
dc.subject | Welt | |
dc.title | Prioritäten für den globalen Aids-Fonds: eine ökonomische Analyse | |
dc.type | doc-type:article |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |